is feeling shroomy
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still here with ya buddy. Just don't use this site much anymore. Loading zone IMO... lots of hints that offtake conversations are on track from Lake's socials and Steve's sentiments in recent interviews.
Congrats all here! Exciting time to be a part of this company.
$MMEDF $MNMD $MMED Congrats to all who are invested in this amazing company. Psychedelics are likely a huge part of the future of mental health treatment and therapy. To be a part of this is more than just a financial reward. 🍄💕🤟
— DGTrader55 (@DGTrader55) April 23, 2021
I assume that the ability to convert will change on uplist or as liquidity increases. I also agree that without live data and more liquidity like on the NEO, it is premature to buy them on US markets. I was simply stating the tickers are now available, which is a good sign, IMO.
Warrants trade just like the stocks do but with more volatility. They have an expiration which is the date in which warrants no longer trade and become worthless (the company can announce a close of trading of their warrants ahead of this date with a 30 day warning). Holders of warrants can convert their warrants to shares at a specified purchase price represented by the warrant.
Warrants have a chance to provide a large reward for a lot less of an investment, but they also have the opportunity to expire with no value. In essence, it is a good way to be exposed to a stock you are bullish on without having to put up as much capital to see substantial returns, but the risk is that it is easy to lose that capital if the common stock doesn't see the returns you expect in the timeframe specified by the warrant.
Also, I honestly have no idea how the warrants work on US exchanges in current form. Not seeing live quotes like you can on the NEO exchange.
More Warrants now available in US on TDAmeritrade.
The broker offers tickers MMDWF, MMCWF, and MMDCF. MMDWF has been trading since beginning February but the others were just added this week.
The news hasn't even started yet in my opinion. I think the recent run has been the market catching up with what they missed
Bid now at .02... Yesterday there was a bid at .02 for 100k shares and it got sold into instantly. Now it has been sitting for about 20 minutes.
That is 500 more than they had in their last filing
Nice to see those .0097s gone for good. Either you sell at half a penny or buy at 2.
Got my eyes peeled here as well. I had picked up a nice lotto chunk around .005s and suddenly up 4x. Holding on to see what happens here.
Sleeper of the space. Once she wakes, she will wake big.
WOW! HUGE block buys coming in... 800k, 250k, 600k.... someone is loading
They released quarter results if you didn't see that. It was a combination of all the news and likely some institutions realizing how undervalued Lake was to its peers. Fully financed to construction phase is incredible. I still hold over half of my original holdings from .028. This should be worth 1b MC in my opinion.
Enjoyed this ride with you ImTC... took some profits today finally but still got majority of my shares. Congrats buddy... and all longs!
32% day on the ASX.. we flying! 32mil shares also
What a day!! This is going to be a fun year
up to 13 cents on the ASX. https://au.investing.com/equities/lake-resources-nl-advanced-chart
Above .10 on ASX means we move in half cent increments there. That means those investing must slap the ask at .105 or wait for sells.
HUGE move on the ASX last night. .096 close=.074 USD. get ready, boys, cuz here we go
HUGE buys. They are coming.
Huge volume off the bat with 800k bought into the .066 ask.. some huge buys and accumulation. Pretty soon, our volume will pass the ASX
Shouldn't be. No halts listed for neo or OTC.. 4 minutes til market opens.
Insider buying!!!
"Subscriptions by insiders of the Company accounted for approximately $1,320,000 of the gross proceeds of the Offering."
https://www.otcmarkets.com/stock/MMEDF/news/MindMed-Closes-Upsized-Financing-of-CAD-921m-USD-727m-to-Meet-High-Investor-Demand?id=285437
Golden opportunity for entry or to add to positions. Get in before the crowd.
Can't wait to see what's in store for this year. ASX surged to over .08 to start off 2021 and is currently trading in upper 7s. Happy new year everyone!
Some bigger buys coming in at 57 and now in 6s
9% move on ASX tonight. Looking good for tomorrow if this holds. We wanted to break into the 6s again today.
Good night on the ASX last night. Getting excited for 2021 and all the catalysts to come.
I C No Movement is moving???
Loading zone here. Dips are opportunities
Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials
DENVER, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has engaged ethica CRO ("ethica CRO"), a full-service Contract Research Organization (“CRO”) that conducts and manages ethical clinical research on drugs, biologics, medical devices and more, as the contract research organization ("CRO") for its upcoming Phase 2A PTSD clinical trials.
ethica CRO is a full-service, global CRO that provides drug development services to biopharmaceutical companies in clinical trials. ethica CRO provides a complete range of clinical study management and biometrics services for clinical research phases I through IV. Since its inception in 2002, ethica CRO has dedicated its efforts to bring a new dimension to the clinical research industry, the ethical dimension, focused on integrating research participants as partners in research rather than simply subjects of research. ethica CRO was the first CRO in the world to be accredited for its human research protection program in 2006 and is the only CRO in the world to have achieved accreditation from three different accrediting bodies
"We are excited to bring on a high-caliber partner in ethica CRO, which has extensive expertise in managing clinical studies to the highest standards of ethical and clinical practice, as the CRO for Mydecine’s upcoming Phase 2A PTSD clinical trials," commented Josh Bartch, CEO of Mydecine Innovations Group. "Engaging ethica CRO is one of the key pieces of our preparations as we explore how the brain responds to psychedelics and develop a better understanding of the biological underpinnings created by the psychedelic experience. We maintain that their insight and unparalleled experience in trials of this nature provide the best opportunity to further drive Mydecine's clinical development. We believe that with ethica CRO’s deep clinical experience, and through our achievements in trial preparation, we are optimally positioned for our upcoming Phase 2A PTSD clinical trials in Veterans in Canada and the United States."
ethica CRO’s dedication to research participant protection made it a partner of choice for the Canadian Department of National Defence. ethica CRO has participated in a series of clinical development programs with the Canadian DND and various NATO allies, most notably synthetic cannabinoids in the treatment of PTSD, injectable antidotes to chemical weapons, and skin decontamination kits for neutralizing chemical warfare agents.
“Psychedelics and psychedelic-assisted therapies are rapidly proving to be some of the most exciting developments in mental health treatment in decades,” said Murray Jensen, Managing Director of ethica CRO. “Mydecine’s ambitious approach to researching and tackling the mental health challenges facing veterans and other frontline workers aligns with our values and mission at ethica and we are excited to hit the ground running with the Mydecine team as they push forward in their pursuit to transform mental health.”
Mydecine’s international Phase 2A clinical trials will focus on psilocybin-assisted psychotherapy to treat chronic PTSD in veterans and EMS personnel. The research will take place at Leiden University Medical Centre in the Netherlands; the University of Western Ontario; and the University of Alberta, with other clinical sites on the horizon in the USA, Europe, and Australia. Through these trials, Mydecine hopes to establish the safety and efficacy of psychedelic administered psychotherapy in a safe and supervised setting, utilizing strict protocols approved by research ethics boards and build upon the body of work that has led to psilocybin-assisted psychotherapy to receive “breakthrough” status by the FDA.
https://www.otcmarkets.com/stock/MYCOF/news/story?e&id=1770933
A lot of filings came in on Friday through the CSE. Make sure to do your DD!
We NEED this medicine to get approved to help prevent a potential global catastrophe. There is no better space to be invested in. Not only should it pay off monetarily, but to know that you helped invest in what could be a catalyst for world change is incomparable.
11% of us adults considered suicide in June
As of now, I dont think any other brands are doing these transdermal patches and wonder if the potential for patent infringement has been a deterrent for other companies to make their own. Please correct me if I'm wrong though. I think Mary's is a diamond waiting to be found.
I posted links to their actual patents in my last post but here is the abstract from their patent pending
Abstract
The present invention includes a transdermal patch which contains a pharmaceutically effective amount of a cannabinoid for delivery of the cannabinoid to the bloodstream of a user. The patch may comprise the following components: a backing; and a skin-adhesive polymer matrix attached to one side of the backing, which includes a cannabinoid, a carrier agent, a terpene, and a permeation agent. The cannabinoid is capable of diffusing from the matrix in the transdermal patch into the bloodstream of the user, and may be used in methods for treating a patient suffering from a condition such as pain, nausea and emesis, convulsions, muscle spasm, inflammation, depression, and cachexia.
Further digging we are patent pending on the patch! If this gets approved then it's over. https://patents.google.com/patent/US20200338041A1/en
https://patents.google.com/?inventor=Noel+Erwin+Palmer here are the three patents we have or are pending